Consumption of Bovine Spongiform Encephalopathy (BSE) Contaminated Beef and the Risk of Variant Creutzfeldt‐Jakob Disease
暂无分享,去创建一个
[1] M. Arnold,et al. Pathogenesis of experimental bovine spongiform encephalopathy (BSE): estimation of tissue infectivity according to incubation period§ , 2008, Veterinary research.
[2] H. Laude,et al. Prion agent diversity and species barrier. , 2008, Veterinary research.
[3] F. V. van Zijderveld,et al. TSE pathogenesis in cattle and sheep. , 2008, Veterinary research.
[4] Arie H. Havelaar,et al. The future of BSE Risk Assessments , 2007 .
[5] Aline A. De Koeijer. Analyzing BSE Transmission to Quantify Regional Risk , 2007 .
[6] Didier Calavas,et al. Complementary Approach of Data Analysis and Modeling to Estimate the Pattern of the BSE Epidemic: The Example of France , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[7] A. D. de Koeijer,et al. Quantitative Risk Assessment for Bovine Spongiform Encephalopathy in Low‐ or Zero‐Prevalence Countries: The Example of Norway , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[8] A. D. de Koeijer. Analyzing BSE Transmission to Quantify Regional Risk , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[9] N. Speybroeck,et al. Trends in age at detection in cases of bovine spongiform encephalopathy in Belgium: an indicator of the epidemic curve , 2006, Veterinary Record.
[10] P. Gale. BSE risk assessments in the UK: a risk tradeoff? , 2006, Journal of applied microbiology.
[11] J Collinge,et al. Molecular neurology of prion disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[12] E. Grist. Transmissible Spongiform Encephalopathy Risk Assessment: The UK experience , 2005, Risk analysis : an official publication of the Society for Risk Analysis.
[13] F. Mouthon,et al. Risk of oral infection with bovine spongiform encephalopathy agent in primates , 2005, The Lancet.
[14] L. Schonberger,et al. The public health impact of prion diseases. , 2005, Annual review of public health.
[15] P. Comer,et al. Exposure of the human population to BSE infectivity over the course of the BSE epidemic in Great Britain and the impact of changes to the Over Thirty Month Rule , 2004 .
[16] D. Dormont,et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection , 2004, The Lancet.
[17] R. Curnow,et al. Repeated challenge with prion disease: The risk of infection and impact on incubation period , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] Christl A Donnelly,et al. Assessment of the risk posed by bovine spongiform encephalopathy in cattle in Great Britain and the impact of potential changes to current control measures , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[19] S. Norley,et al. Prion diseases: infectious and lethal doses following oral challenge. , 2003, The Journal of general virology.
[20] A. Ghani,et al. Short-term projections for variant Creutzfeldt-Jakob disease onsets , 2003, Statistical methods in medical research.
[21] S. Cousens,et al. The predictability of the epidemic of variant Creutzfeldt-Jakob disease by back-calculation methods , 2003, Statistical methods in medical research.
[22] R. Kulkarni,et al. Theoretical modeling of prion disease incubation. , 2001, Biophysical journal.
[23] A. Bouma,et al. Factors that influence the age distribution of BSE cases: potentials for age targeting in surveillance , 2002 .
[24] A. Ghani,et al. The transmission dynamics of BSE and vCJD. , 2002, Comptes rendus biologies.
[25] Cooper Jd,et al. UK dietary exposure to BSE in beef mechanically recovered meat: by birth cohort and gender. , 2002 .
[26] S. Bird,et al. UK dietary exposure to BSE in beef mechanically recovered meat: by birth cohort and gender. , 2002, Journal of cancer epidemiology and prevention.
[27] A. Valleron,et al. Estimation of Epidemic Size and Incubation Time Based on Age Characteristics of vCJD in the United Kingdom , 2001, Science.
[28] S. Cousens,et al. Predictability of the UK Variant Creutzfeldt-Jakob Disease Epidemic , 2001, Science.
[29] K. McDonnell,et al. Predictive modelling and risk assessment of BSE: a review , 2001 .
[30] J. Hauw,et al. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt– Jakob disease: Implications for human health , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. McLean,et al. Scrapie infections initiated at varying doses: an analysis of 117 titration experiments. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[32] Christl A. Donnelly,et al. Predicted vCJD mortality in Great Britain , 2000, Nature.
[33] M. Williams,et al. Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific Affairs. American Medical Association. , 1999, JAMA.
[34] P. Gale. Quantitative BSE risk assessment: relating exposures to risk , 1998, Letters in applied microbiology.
[35] R. Anderson,et al. Estimation of the number of people incubating variant CJD , 1998, The Lancet.
[36] N M Ferguson,et al. The epidemiology of BSE in cattle herds in Great Britain. II. Model construction and analysis of transmission dynamics. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[37] C. Donnelly,et al. Transmission dynamics and epidemiology of BSE in British cattle , 1997, Nature.
[38] R. G. Will,et al. Predicting the CJD epidemic in humans , 1997, Nature.
[39] J. Hauw,et al. BSE transmission to macaques , 1996, Nature.
[40] Sheldon M. Ross,et al. Stochastic Processes , 2018, Gauge Integral Structures for Stochastic Calculus and Quantum Electrodynamics.